← FDA Drug Approvals (Drugs@FDA)

INGREZZA SPRINKLE

NDA · New Drug Application · Sponsor: NEUROCRINE · Approved 2024-04-30

Drug application

FDA Application #

NDA218390

Application type

New Drug Application

Brand name

INGREZZA SPRINKLE

Generic name

VALBENAZINE

Active ingredients

VALBENAZINE TOSYLATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

NEUROCRINE

Manufacturer

Neurocrine Biosciences, Inc.

First approval

2024-04-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown